SK

Sudhir Kashiram Marne

Active Director Director DIN 07521670
DIN 07521670 First appointment Jul 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2016
Shareholding value •••• Premium profile

About Sudhir Kashiram Marne

Data last updated:

Sudhir Kashiram Marne is a Director at Medicyte Pharmaceutical Private Limited (since 2016). The company operates in Pharma. Medicyte Pharmaceutical Private Limited reported revenue of ₹2.60 Cr (FY 2025).

DIN 07521670
Primary Designation Director
Industry Pharma
First Appointment 04 Jul 2016
Oldest Company Age 10 yrs
Largest company Medicyte Pharmaceutical Private Limited · ₹2.60 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Jul 20162016₹2.60 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Medicyte Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Sudhir Kashiram Marne

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sudhir Kashiram Marne

Sudhir Kashiram Marne currently holds 1 directorship: Medicyte Pharmaceutical Private Limited (Director, since 04 Jul 2016, revenue ₹2.60 Cr (FY 2025)).

Sudhir Kashiram Marne was first appointed on 04 Jul 2016 as Director at Medicyte Pharmaceutical Private Limited.

The current boards of Sudhir Kashiram Marne's companies include Ashok Kashiram Tetgure (Medicyte Pharmaceutical Private Limited), Shailesh Prabhakar Gharat (Medicyte Pharmaceutical Private Limited), Shirish Chandrakant Chavan (Medicyte Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available